| Literature DB >> 26733285 |
Jessica Becker1,2, Stephan L Haas3, Anna Mokrowiecka4, Justyna Wasielica-Berger5, Zeeshan Ateeb3, Jonna Bister3, Peter Elbe3, Marek Kowalski4, Magdalena Gawron-Kiszka6, Marek Majewski7, Agata Mulak8, Maria Janiak9, Mira M Wouters10, Till Schwämmle1,2, Timo Hess1,2, Lothar Veits11, Stefan Niebisch12, José L Santiago13, Antonio Ruiz de León14, Julio Pérez de la Serna14, Elena Urcelay13, Vito Annese15, Anna Latiano16, Uberto Fumagalli17, Riccardo Rosati18, Luigi Laghi19, Rosario Cuomo20, Frank Lenze21, Giovanni Sarnelli20, Michaela Müller22, Burkhard Ha von Rahden23, Cisca Wijmenga24, Hauke Lang25, Kamila Czene26, Per Hall26, Paul Iw de Bakker27,28, Michael Vieth11, Markus M Nöthen1,2, Henning G Schulz29, Krystian Adrych9, Anita Gąsiorowska4, Leszek Paradowski8, Grzegorz Wallner7, Guy E Boeckxstaens10, Ines Gockel12, Marek Hartleb6, Srdjan Kostic3, Anna Dziurkowska-Marek6, Mats Lindblad3, Magnus Nilsson3, Michael Knapp30, Anders Thorell31, Tomasz Marek6, Andrzej Dąbrowski5, Ewa Małecka-Panas4, Johannes Schumacher1,2.
Abstract
Idiopathic achalasia is a severe motility disorder of the esophagus and is characterized by a failure of the lower esophageal sphincter to relax due to a loss of neurons in the myenteric plexus. Most recently, we identified an eight-amino-acid insertion in the cytoplasmic tail of HLA-DQβ1 as strong achalasia risk factor in a sample set from Central Europe, Italy and Spain. Here, we tested whether the HLA-DQβ1 insertion also confers achalasia risk in the Polish and Swedish population. We could replicate the initial findings and the insertion shows strong achalasia association in both samples (Poland P=1.84 × 10(-04), Sweden P=7.44 × 10(-05)). Combining all five European data sets - Central Europe, Italy, Spain, Poland and Sweden - the insertion is achalasia associated with Pcombined=1.67 × 10(-35). In addition, we observe that the frequency of the insertion shows a geospatial north-south gradient. The insertion is less common in northern (around 6-7% in patients and 2% in controls from Sweden and Poland) compared with southern Europeans (~16% in patients and 8% in controls from Italy) and shows a stronger attributable risk in the southern European population. Our study provides evidence that the prevalence of achalasia may differ between populations.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26733285 PMCID: PMC4970678 DOI: 10.1038/ejhg.2015.262
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246